Notice for plozasiran (Arrowhead Australia Pty Ltd)
Active ingredients
plozasiran
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for injection
Indication
For the treatment of genetically confirmed or clinically diagnosed familial chylomicronaemia syndrome
Therapeutic area
Cardiovascular